Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early ECP for GVHD Prevention After Allo-HSCT
NCT00930566Phase 2Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methoxsalen in graft-versus-host disease (GVHD), sponsored by Hospices Civils de Lyon. Status: unknown.
02
Drugs
methoxsalen
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00930566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930566.